Literature DB >> 23184995

Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry.

Edita Navratilova1, Jennifer Y Xie, Alec Okun, Chaoling Qu, Nathan Eyde, Shuang Ci, Michael H Ossipov, Tamara King, Howard L Fields, Frank Porreca.   

Abstract

Relief of pain is rewarding. Using a model of experimental postsurgical pain we show that blockade of afferent input from the injury with local anesthetic elicits conditioned place preference, activates ventral tegmental dopaminergic cells, and increases dopamine release in the nucleus accumbens. Importantly, place preference is associated with increased activity in midbrain dopaminergic neurons and blocked by dopamine antagonists injected into the nucleus accumbens. The data directly support the hypothesis that relief of pain produces negative reinforcement through activation of the mesolimbic reward-valuation circuitry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184995      PMCID: PMC3528534          DOI: 10.1073/pnas.1214605109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates.

Authors:  T S Shippenberg; A Herz; R Spanagel; R Bals-Kubik; C Stein
Journal:  Ann N Y Acad Sci       Date:  1992-06-28       Impact factor: 5.691

Review 2.  Reward representations and reward-related learning in the human brain: insights from neuroimaging.

Authors:  John P O'Doherty
Journal:  Curr Opin Neurobiol       Date:  2004-12       Impact factor: 6.627

Review 3.  Imaging valuation models in human choice.

Authors:  P Read Montague; Brooks King-Casas; Jonathan D Cohen
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

Review 4.  Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement.

Authors:  Howard L Fields; Gregory O Hjelmstad; Elyssa B Margolis; Saleem M Nicola
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

5.  Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release.

Authors:  Z X Xi; E A Stein
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

6.  The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites.

Authors:  M C Olmstead; K B Franklin
Journal:  Behav Neurosci       Date:  1997-12       Impact factor: 1.912

Review 7.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

8.  High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner.

Authors:  G A Hargreaves; G E Hunt; J L Cornish; I S McGregor
Journal:  Neuroscience       Date:  2007-02-06       Impact factor: 3.590

9.  Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection.

Authors:  M M Garcia; H E Brown; R E Harlan
Journal:  Brain Res       Date:  1995-09-18       Impact factor: 3.252

10.  Understanding how opioids contribute to reward and analgesia.

Authors:  Howard L Fields
Journal:  Reg Anesth Pain Med       Date:  2007 May-Jun       Impact factor: 6.288

View more
  141 in total

Review 1.  The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?

Authors:  Patrick H Finan; Bethany Remeniuk; Kelly E Dunn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-01       Impact factor: 5.067

2.  Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans.

Authors:  L Becerra; E Navratilova; F Porreca; D Borsook
Journal:  J Neurophysiol       Date:  2013-06-19       Impact factor: 2.714

3.  Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.

Authors:  Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

4.  Frontostriatal network dysfunction as a domain-general mechanism underlying phantom perception.

Authors:  Jeffrey Hullfish; Ian Abenes; Hye Bin Yoo; Dirk De Ridder; Sven Vanneste
Journal:  Hum Brain Mapp       Date:  2019-01-15       Impact factor: 5.038

Review 5.  Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data.

Authors:  Thomas S W Park; Andy Kuo; Maree T Smith
Journal:  Inflammopharmacology       Date:  2018-05-12       Impact factor: 4.473

Review 6.  Neural mechanisms of pain and alcohol dependence.

Authors:  A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan
Journal:  Pharmacol Biochem Behav       Date:  2013-10-02       Impact factor: 3.533

7.  Separating analgesia from reward within the ventral tegmental area.

Authors:  E Schifirneţ; S E Bowen; G S Borszcz
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

8.  Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.

Authors:  Launette Marie Rieb; Kora DeBeck; Kanna Hayashi; Evan Wood; Ekaterina Nosova; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-08-18       Impact factor: 4.492

Review 9.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

10.  AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain.

Authors:  Chen Su; Hau Yeuh Lin; Runtao Yang; Duo Xu; Michelle Lee; Natalie Pawlak; Monica Norcini; Alexandra Sideris; Esperanza Recio-Pinto; Dong Huang; Jing Wang
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.